Sirmour Remedies Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 08-07-2024
- Paid Up Capital ₹ 1.00 Cr
as on 08-07-2024
- Company Age 35 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.96 Cr
as on 08-07-2024
- Satisfied Charges ₹ 1.73 Cr
as on 08-07-2024
- Revenue 4.91%
(FY 2022)
- Profit 5.97%
(FY 2022)
- Ebitda -24.33%
(FY 2022)
- Net Worth 12.04%
(FY 2022)
- Total Assets 14.98%
(FY 2022)
About Sirmour Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹5.96 Cr. The company has closed loans amounting to ₹1.73 Cr, as per Ministry of Corporate Affairs (MCA) records.
Abhay Srivastava, Arjun Singh, Nikunj Tyagi, and Three other members serve as directors at the Company.
- CIN/LLPIN
U15311HP1989PTC009770
- Company No.
009770
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Oct 1989
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- Location
Sirmaur, Himachal Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Sirmour Remedies?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhay Srivastava  | Director | 01-Mar-2021 | Current |
| Arjun Singh | Director | 12-Jan-2017 | Current |
| Nikunj Tyagi | Director | 22-Aug-2005 | Current |
| Kanwal Singh | Additional Director | 05-Jun-2023 | Current |
| Shyam Lal | Director | 02-May-2003 | Current |
| Akhlas Ahmed | Director | 01-Mar-2021 | Current |
Financial Performance and Corporate Structure Insights of Sirmour Remedies.
Sirmour Remedies Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 4.91% increase. The company also saw a slight improvement in profitability, with a 5.97% increase in profit. The company's net worth Soared by an impressive increase of 12.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sirmour Remedies?
In 2022, Sirmour Remedies had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Relax Pharmaceuticals Private LimitedActive 27 years 4 monthsAbhay Srivastava and Akhlas Ahmed are mutual person
Copmed Pharmaceuticals Private LimitedActive 36 years 3 monthsAbhay Srivastava and Akhlas Ahmed are mutual person
Mediforce Healthcare Private LimitedActive 23 years 10 monthsAbhay Srivastava, Nikunj Tyagi and 1 more are mutual person
Mankind Medicare Private LimitedActive 1 year 3 monthsAbhay Srivastava and Akhlas Ahmed are mutual person
- Mankind Life Sciences Private LimitedActive 4 years 3 months
Abhay Srivastava and Akhlas Ahmed are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 16 Sep 2021 | ₹9.57 M | Open |
Hdfc Bank Limited Creation Date: 29 Oct 2018 | ₹5.00 Cr | Open |
Member Secretary Creation Date: 05 Sep 2009 | ₹2.30 M | Satisfied |
How Many Employees Work at Sirmour Remedies?
Sirmour Remedies has a workforce of 260 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sirmour Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sirmour Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
